Filing Details

Accession Number:
0001104659-16-127973
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-17 10:51:14
Reporting Period:
2016-06-16
Filing Date:
2016-06-17
Accepted Time:
2016-06-17 10:51:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1626199 Nivalis Therapeutics Inc. NVLS Pharmaceutical Preparations (2834) 208969493
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1644975 Jon Congleton C/O Nivalis Therapeutics, Inc.
3122 Sterling Circle, Suite 200
Boulder CO 80301
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-06-16 5,000 $3.87 20,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price recorded in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.8689 to $3.87, inclusive. The reporting person undertakes to provide Nivalis Therapeutics, Inc., any security holder of Nivalis Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.